Table 1 Population statistics of patients with newly diagnosed GBM

Median age at diagnosis

61.0

Average age at death

60.5

Gender

M

44

60 %

F

29

40 %

Extent of resection

GTR

38

52 %

STR

24

33 %

Biopsy

11

15 %

Median RT dose

6000

Concurrent agents

Temozolomide alone

39

53 %

Temozolomide and Bevacizumab

34

47 %

Smoker

No

43

60 %

Yes

29

40 %

HTN

No

32

44 %

Yes

41

56 %

BMI

Normal (<25)

17

23 %

Overweight (25–30)

37

51 %

Obese (>30)

19

26 %

DM

No

63

86 %

Yes

10

14 %

Hyperlipidemia

No

46

63 %

Yes

27

37 %

Dexamethasone during RT

No

37

51 %

Yes

36

49 %